retatrutide or ozempic Promises Big Weight Loss, but Safety Remains a Question Comparing the Big 3, Semaglutide,

The interim analysis at 20% enrollment was conducted to reassess the adequacy of the sample size, given the lack of high-quality prospective data available at the time of study design

A/P: 1.22 mm, M/L: 1.125 mm, D/V: 4.83 mm)

Our hope is that research on both berberine and Ozempic will be published showing successful DEXA scans that maintain muscle tissue with high-protein diets, and when that's the case, we'll be a bit more confident in the more aggressive interventions

History of Semaglutide and Phentermine Semaglutide was developed by Novo Nordisk as a treatment for type 2 diabetes and marketed as Ozempic in 2017, followed by an oral form called Rybelsus in 2019